Dosing characteristics of oral treprostinil in real-world clinical practice

por Balasubramanian, Vijay P., Messick, Chad R., Broderick, Meredith, Nelsen, Andrew C.
Publicado 2018

Treatment satisfaction is associated with improved quality of life in patients treated with inhaled treprostinil for pulmonary arterial hypertension

por Chen, Hubert, Rosenzweig, Erika B, Gotzkowsky, S Karl, Arneson, Carl, Nelsen, Andrew C, Bourge, Robert C
Publicado 2013

Implantable system for treprostinil: a real-world patient experience study

por Shapiro, Shelley, Bourge, Robert C., Pozella, Patti, Harris, David F., Borg, Erick H., Nelsen, Andrew C.
Publicado 2020

Correction to: Medication Adherence and Healthcare Costs Among Patients with Pulmonary Arterial Hypertension Treated with Oral Prostacyclins: A Retrospective Cohort Study

por Dean, Bonnie B., Saundankar, Vishal, Stafkey-Mailey, Dana, Anguiano, Rebekah H., Nelsen, Andrew C., Gordon, Kathryn, Classi, Peter
Publicado 2020

Medication Adherence and Healthcare Costs Among Patients with Pulmonary Arterial Hypertension Treated with Oral Prostacyclins: A Retrospective Cohort Study

por Dean, Bonnie B., Saundankar, Vishal, Stafkey-Mailey, Dana, Anguiano, Rebekah H., Nelsen, Andrew C., Gordon, Kathryn, Classi, Peter
Publicado 2020

Survival and drug persistence in patients receiving inhaled treprostinil at doses greater than 54 µg (nine breaths) four times daily

por Shapiro, Shelley, Mandras, Stacy, Restrepo-Jaramillo, Ricardo, Shen, Eric, Broderick, Meredith, Rao, Youlan, Lee, Dasom, Nelsen, Andrew C.
Publicado 2021

Real‐world dosing characteristics and utilization of parenteral treprostinil in the outpatient setting

por Balasubramanian, Vijay P., Safdar, Zeenat, Sketch, Margaret R., Broderick, Meredith, Nelsen, Andrew C., Lee, Dasom, Melendres‐Groves, Lana
Publicado 2022

Impact of inhaled treprostinil on risk stratification with noninvasive parameters: a post hoc analysis of the TRIUMPH and BEAT studies

por Tonelli, Adriano R., Sahay, Sandeep, Gordon, Kathryn W., Edwards, Lisa D., Allmon, Andrew G., Broderick, Meredith, Nelsen, Andrew C.
Publicado 2020

Development of the Pulmonary Hypertension Functional Classification Self-Report: a patient version adapted from the World Health Organization Functional Classification measure

por Highland, Kristin B., Crawford, Rebecca, Classi, Peter, Morrison, Ross, Doward, Lynda, Nelsen, Andrew C., Castillo, Howard, Mathai, Stephen C., DuBrock, Hilary M.
Publicado 2021

Identifying Patients with Pulmonary Arterial Hypertension Using Administrative Claims Algorithms

por Mathai, Stephen C., Hemnes, Anna Ryan, Manaker, Scott, Anguiano, Rebekah H., Dean, Bonnie B., Saundankar, Vishal, Classi, Peter, Nelsen, Andrew C., Gordon, Kathryn, Ventetuolo, Corey E.
Publicado 2019

Pulmonary hypertension due to interstitial lung disease or chronic obstructive pulmonary disease: a patient experience study of symptoms and their impact on quality of life

por DuBrock, Hilary M., Nathan, Steven D., Reeve, Bryce B., Kolaitis, Nicholas A., Mathai, Stephen C., Classi, Peter M., Nelsen, Andrew C., Olayinka-Amao, Bimpe, Norcross, Lindsey N., Martin, Susan A.
Publicado 2021

Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension

por Bourge, Robert C, Tapson, Victor F, Safdar, Zeenat, Benza, Raymond L, Channick, Richard N, Rosenzweig, Erika B, Shapiro, Shelley, White, Richard James, McSwain, Christopher Shane, Gotzkowsky, Stephen Karl, Nelsen, Andrew C, Rubin, Lewis J
Publicado 2013